Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene

Biochemical and Biophysical Research Communications

Volumn 247, Issue 1, 1998, Pages 94-99

  Moisset, Pierre Alain ^a   Skuk, Daniel ^a,b   Asselin, Isabelle ^b   Goulet, Marlyne ^b   Roy, Brigitte ^b   Karpati, George ^c   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b HOSPITAL DE CLÍNICAS   (Uruguay)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL CULTURE; CELL DIVISION; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNITY; MOUSE; MUSCLE BIOPSY; MYOBLAST; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCID MOUSE; TRANSGENE;

ADENOVIRIDAE; ANIMALIA;

EID: 0032499588     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8739     Document Type: Article

References (38)

1. Gussoni E., Pavlath G. K., Lanctot A. M., Sharma K. R., Miller R. G., Steinman L., Blau H. M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 356:1992;435-438.
2. Karpati G., Ajdukovic D., Arnold D., Gledhill R. B., Guttman R., Holland P., Koch P. A., Shoubridge E., Spence D., Vanasse M., Watters G. V., Abrahamowicz M., Duff C., Worton R. G. Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34:1993;8-17.
3. Tremblay J. P., Bouchard J. P., Malouin F., Théau D., Cottrell F., Collin H., Rouche A., Gilgenkrantz S., Abbadi N., Tremblay M., Tomé F. M. S., Fardeau M. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromusc. Disord. 3:1993;583-592.
4. Law P. K., Goodwin T. G., Fang Q., Deering M. B., Duggirala V., Larkin C., Florendo J. A., Li H. J., Chen M., Cormett J., Li L. M., Shirzad A., Quinley T., Yoo T. J., Holcomb R. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant. 2:1993;485-505.
5. Mendell J. R., Kissel J. T., Amato A. A., King W., Signore L., Prior T. W., Sahenk Z., Benson S., McAndrew P. E., Rice R., Nagaraja H., Stephens R., Lantry L., Morris G. E., Burghes A. H. M. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:1995;832-838.
6. Ito, H. Tremblay, J. P. Prior culture with concavalin A increases intramuscular migration of transplanted myoblasts, Muscle Nerve.
7. Huard J., Acsadi G., Jani A., Massie B., Karpati G. Gene therapy into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:1994;949-958.
8. Beauchamp J. R., Morgan J. E., Pagel C. N., Partridge T. A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve Suppl. 4:1994;S261.
9. Beauchamp J. R., Pagel C. N., Partridge T. A. A dual-marker system for quantitative studies of myoblast transplantation in the mouse. Transplantation. 63:1997;1794-1797.
10. Vilquin J. T., Asselin I., Guérette B., Kinoshita I., Lille S., Roy R., Tremblay J. P. Myoblast allotransplantation in mice: Degree of success varies depending on the efficiency of various immunosuppressive treatments. Transplant. Proc. 26:1994;3372-3373.
11. Vilquin J. T., Asselin I., Guérette B., Kinoshita I., Roy R., Tremblay J. P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation. 59:1995;422-449.
12. Kinoshita I., Roy R., Dugré F. J., Gravel C., Roy B., Goulet M., Asselin I., Tremblay J. P. Myoblast transplantation in monkeys: Control of immune response by FK506. J. Neuropath. Exp. Neurol. 55:1996;687-697.
13. Kinoshita I., Vilquin J. T., Guérette B., Asselin I., Roy R., Tremblay J. P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve. 17:1994;1407-1415.
14. Guérette B., Gingras M., Wood K., Roy R., Tremblay J. P. Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice. Transplantation. 62:1996;962-967.
15. Boulanger A., Tremblay J. P. Role of non-MHC antigens in the rejection of transplanted myoblasts. Transplantation. 63:1997;893-899.
16. McDiarmid S. V., Busuttil R. W., Ascher N. L., Burdick J., D'Alessandro A. M., Esquivel C., Kalayoglu M., Klein A. S., Marsh J. W., Miller C. M., Schwartz M. E., Shaw B. W., So S. K. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation. 59:1995;530-536.
17. Petrof B. J., Acsadi G., Jani A., Massie B., Bourdon J., Matusiewicz N., Yang L., Lochmuller H., Karpati G. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. Am. J. Cell Mol. Biol. 13:1995;508-517.
18. Haecker S. E., Stedman H. H., Balice-Gordon R. J., Smith D. B. J., Greelish J. P., Mitchell M. A., Wells A., Sweeney H. L., Wilson J. M. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum. Gene Ther. 7:1996;1907-1914.
19. Kochanek S., Clemens P. R., Mitani K., Chen H. H., Chan S., Caskey C. T. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA. 93:1996;5731-5736.
20. Kumar-Singh R., Chamberlain J. S. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5:1996;913-921.
21. Deconinck N., Ragot T., Maréchal G., Perricaudet M., Gillis J. M. Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. USA. 93:1996;3570-3574.
22. Feero W. G., Rosenblatt J. D., Huard J., Watkins S. C., Epperly M., Clemens P. R., Kochanek S., Glorioso J. C., Partridge T. A., Hoffman E. P. Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type I viral vectors. Hum. Gene Ther. 8:1997;371-380.
23. Tremblay J. P., Guérette B. Myoblast transplantation: A brief review of the problems and of some solutions. Basic Appl. Myol. 7:1997.
24. Cossu G., Zani B., Coletta M., Bouche M., Pacifict M., Molinaro M. In vitro differentation of satelite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. Cell Differ. 9:1980;357-365.
25. England S. B., Nicholson L. V. B., Johnson M. A., Forrest S. M., Love D. R., Zubrzycka-Gaarn E. E., Bulman D. E., Harris J. B., Davies K. E. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature. 343:1990;180-182.
26. Acsadi G., Lochmüller H., Jani A., Huard J., Massie B., Prescott S., Simoneau M., Petrof B., Karpati G. Dystrophin expression in muscles of mdx mice after adenovirus-mediatedin vivo. Hum. Gene Ther. 7:1996;129-140.
27. Weller B., Karpati G., Lehnert S., Carpenter S., Ajdukovic B., Holland P. Inhibition of myosatelite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice. Am. J. Pathol. 138:1991;1497-1502.
28. Wakeford S., Watt D. J., Partridge T. A. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve. 14:1991;42-50.
29. Wirtz P., Loermans H., Rutten E. Effects of irradiation on regeneration in dystrophic mouse leg muscle. Br. J. Exp. Pathol. 63:1982;671-679.
30. Harris J. B., Johnson M. A., Karlsson E. Pathological responses of rat skeletal muscle to a single subcuteneous injection of a toxin from the venom of the Australian tiger snake, Notechis scutatus scutatus. Clin. Exp. Pharm. Physiol. 2:1975;383-404.
31. Morgan C. J., Hernandez C. J., Ward J. S., Orosz C. G. Detection of cytokine mRNA in vivo by polymerase chain reaction. Transplantation. 56:1993;437-443.
32. Yang Y., Nunes A. F., Berencsi K., Furth E. E., Gönczöl E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407-4411.
33. Yang Y., Li Q., Ertl H. C. J., Wilson J. M. Cellular and humoral immune responses to viral antigens create varriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:1995;2004-2015.
34. Engelhardt J. F., Litzky L., Wilson J. M. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2A. Hum. Gene Ther. 5:1994;1217-1229.
35. Yeh P., Perricaudet M. Advances in adenoviral vectors: From genetic engineering to their biology. FASEB J. 11:1997;615-623.
36. Floyd S. S., Clemens P. R., Ontell M. R., Kochanek S., Day C. S., Yang J., Hauschka S. D., Balkir L., Morgan J., Moreland M. S., Feero G. W., Epperly M., Huard J. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther. 5:1998;19-30.
37. Snyder R. O., Spratt S. K., Lagarde C., Bohl D., Kaspar B., Sloan B., Cohen L. K., Danos O. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice. Hum. Gene Ther. 8:1997;1891-1900.
38. Kremer E. J., Perricaudet M. Adenovirus and adeno-associated virus mediated gene transfer. Brit. Med. Bull. 51:1995;31-44.